Top

Supportive Care in Cancer

Published in:

01-04-1998 | SHORT COMMUNICATION

The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support

Authors: M. A. Climent, Javier Palau, Amparo Ruiz, Virtudes Soriano, Eduardo Aznar, Teresa Olmos, Vicente Guillem

Published in: Supportive Care in Cancer | Issue 3/1998

Title: The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support
Authors: M. A. Climent
Javier Palau
Amparo Ruiz
Virtudes Soriano
Eduardo Aznar
Teresa Olmos
Vicente Guillem
Publication date: 01-04-1998
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 3/1998
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s005200050168

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/1998

Delayed emesis following anticancer chemotherapy

Predictive factors for psychological distress in ambulatory lung cancer patients

Prevention of Pneumocystis carinii pneumonia with cotrimoxazole 18 mg/kg

Epicutaneous breast forms

Oncology Home Care Service

Aetiology and prevention of emesis induced by radiotherapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer